Company news
Spyglass Pharma, Inc. (NASDAQ:SGP) news
Every Spyglass Pharma, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 6, 2026
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
June 15, 2026
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
June 2, 2026
SpyGlass Pharma to Participate in Upcoming Investor Conferences
May 21, 2026
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
May 18, 2026
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 14, 2026
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
March 26, 2026
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
March 9, 2026
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
March 4, 2026
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
February 9, 2026
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 5, 2026